Figure 7.
Systemic administration of recombinant interleukin (rIL)‐2 and anti‐CD25 monoclonal antibody after intrasplenic implantation of MC38/mock cells. (a) Average liver weight in each treatment group. On day 17 after implantation, liver weights were measured. The mean weight ± SD of livers from three different mice is shown. *P < 0.05. (b) Photographs of livers collected on day 17. Three livers from untreated mice (upper left) and mice treated with rIL‐2 alone (upper right), PC61 alone (lower left) and rIL‐2 plus PC61 (lower right) are shown.